Health Canada, Novavax and COVID-19
Moderna Stock Jumps on Canadian Government's Approval of Updated COVID-19 Vaccine
The company reported Health Canada authorized the use of its Spikevax KP.2 shot for those aged six months and older. Last month, the U.S. Food and Drug Administration also gave approval for the vaccine, as well as updated shots from Pfizer ( PFE) and BioNTech ( BNTX ).
Moderna Shares Rise on Canada Government Approval of Updated Covid-19 Vaccine
Shares of Moderna rose after the company said that the government of Canada authorized its updated Covid-19 vaccine, joining the U.S. in the approval. The stock was up 4.5% at $72.28 in Tuesday afternoon trading, becoming the best performing stock of the S&P 500 and Nasdaq 100. The stock has, however, dropped 26% since the beginning of the year.
Health Matters: Canada to use Pfizer's 'Abrysvo' RSV vaccine
Pfizer says Canada has selected its "Abrysvo" RSV vaccine for use in adults 60 and over for the upcoming virus season. "Abrysvo" is also approved for use in pregnant people to provide protection to infants.
Health Canada approves updated Novavax COVID-19 vaccine
According to a Thursday update on the government’s vaccine portal, Health Canada will replace the older version of the protein-based vaccine, Nuvaxovid XBB.1.5. The new version will include an update to the antigen composition targeting the JN.1 variant.
COVID-19 2024 fall guide: Everything Canadians should know about new Moderna vaccine, current variants and more
NACI added that anyone above 6 months of age who isn't considered high risk "may receive the most recently updated vaccine in the fall of 2024." The organization recommends a six-month interval between COVID vaccines, "with a minimum of three months from the last dose."
Health Canada approves Novavax's updated COVID-19 vaccine for fall
Health Canada said Thursday it has authorized Novavax's updated COVID-19 vaccine for those aged 12 years and up. The product, called Nuvaxovid, is a protein-based vaccine. Health Canada said the vaccine was updated to target the JN.
Valneva Seeks Approval To Expand IXCHIQ Chikungunya Vaccine Use To Adolescents In Europe And Canada
Valneva SE (VALN) said that it has submitted label extension applications to the European Medicines Agency (EMA) and Health Canada to ...
devdiscourse10d
Canada Donates Up to 200,000 Mpox Vaccine Doses Amid Global Health Crisis
Canada is donating up to 200,000 doses of the mpox vaccine to counter the global health emergency declared by the WHO. The ...
ABRYSVO™: Pfizer Canada's Newly Publicly Funded Vaccine a Step Towards National RSV Prevention in Older Adults
ULC announced that ABRYSVO™ has been selected as the publicly-funded vaccine for the prevention of Respiratory Syncytial ...
Canada's Only Single-Dose Cholera Vaccine Available Nationwide
In addition to VAXCHORA, the Bavarian Nordic Canada travel health portfolio includes a typhoid vaccine. The company plans to launch a rabies vaccine in the coming months.
Canada to donate 'up to 200,000' doses of mpox vaccine
TORONTO, Sept 11 (Reuters) - Canada is donating "up to 200,000" doses of mpox vaccine, a government spokesperson said on ...
COVID-19 is still spreading in Utah but new vaccines are available. Here’s what experts want you to do
Updated COVID-19 vaccine is now available. With another COVID-19 surge likely coming this winter, University of Utah experts ...